A Clinical Study on the Effect of Yinxing Damo (银杏达莫) Combined with Betahistine Hydrochloride Injection on Vertebral Basilar Artery Ischemic Vertigo

Objective: To evaluate the therapeutic efficacy of Yinxing Damo (银杏达莫, YXDM) combined with Betahistine Hydrochloride Injection (BHI) on vertebra basilar artery ischemic vertigo (VBIV).Methods: Ninety patients with VBIV were randomly divided into two groups; 45 patients (the treated group)were treated with YXDM and BHI intravenous dripping, once a day for 14 days. Another 45 patients (control clinical syndromes and the index of the transcranial Doppler (TCD) and hemorheology were observed. Results: The total effective rate was 100% in the treated group, which was better than that in the control group90.5%, (P＜0.05). The indexes of TCD and hemorheology in the treated group were obviously improved after treatment, (P＜0.01). Conclusion: YXDM combined with BHT injection had better effect in treating patients with VBIV is an ideal drug for VBIV.     

Effects of Shenmai Injection on Blood SOD Activity and MDA Level in Senile Patients with Coronary Heart Disease

In order to approach the effects of Shenmai Injection on SOD activity and MDA level in the senilepatients with coronary heart disease,48 cases,who had stenosis of over 70% in more than one branchesof the coronary arteries,were assigned randomly into a treatment group (given Shenmai Injection plusthe routine treatment) and a control group (given the routine treatment only).The superoxide dismutase(SOD) activity and malondialdehyde (MDA) level were determined before treatment and at the end of a3-week treatment.The results showed that in the treatment group,the SOD activity was significantlyincreased (P<0.05) and the MDA level markedly decreased (P<0.01) in the treatment group.It can beconcluded that Shenmai Injection may enhance the antioxidant ability of the senile patients withcoronary heart disease.     

Clinical observation on the effect of dexamethasone and chinese herbal decoction for purgation in severe acute pancreatitis patients

Objective:To investigate the effect of dexamethasone(Dx) combined with modified Dachengqi Decoction(大承气汤,DCQD),a Chinese herbal decoction for purgation,on patients with severe acute pancreatitis(SAP) accompanied with systematic inflammatory response syndrome(SIRS).Methods:A total of 81 patients diagnosed as SAP were randomly assigned to a control group or treatment group according to a random number table generated from an SPSS software.The patients in the control group(38 cases) received standard treatment and Chinese herbal decoction for purgation;those in the treatment group(43 cases) received additional 1 mg/(kg·d) dexamethasone(Dx) treatment for three days based on the above treatment.The mortality rate,acute respiratory distress syndrome(ARDS),renal failure,hemorrhage,sepsis,pancreatic pseudocyst, pancreatic abscess,operability,and days of hospitalization were compared between the two groups.Results: Three patients in the control group and eight patients in the treatment group dropped out from the study with a drop-out rate of 7.8%and 18.6%,respectively,and no statistics difference was shown between the two groups (P>0.05).Dx treatment significantly reduced ARDS rate and shortened the length of hospitalization compared to those in the control group(7/35,20.0%versus 15/35,42.9%,P=0.0394;32.5±13.2 days versus 40.2±17.5 days,P=0.0344).Other parameters including the mortality rate were not significant different between the two groups.Conclusion:Dx combined with DCQD could decrease the risk of developing ARDS in SAP patients with SIRS and shorten their length of hospitalization.     

Efficacy of Aidi Injection (艾迪注射液) on Overexpression of P-Glycoprotein Induced by Vinorelbine and Cisplatin Regimen in Patients with Non-Small Cell Lung Cancer

Objective:To investigate the efficacy of Aidi Injection(艾迪注射液) on overexpression of P-glycoprotein(P-gp) induced by vinorelbine and cisplatin(NP) regimen in patients with non-small cell lung cancer(NSCLC), and study the difference between intravenous administration and targeting intratumor administration of Aidi Injection with thoracoscope. Methods:Totally 150 patients with NSCLC were randomly assigned to the control group, the intravenous group and the intratumor group by the random envelope method, 50 cases in each group. The patients were treated with NP regimen(2 cycles), NP regimen(2 cycles) plus Aidi intravenous injection, or NP regimen(2 cycles) plus Aidi intratumor injection with thoracoscope, respectively for 6 weeks. The clinical efficacy was observed based on Response Evaluation Criteria in Solid Tumors(RECIST) rules, the expression of P-gp in the tumor tissue was tested before, 3 and 6 weeks after treatment, the safety was evaluated by monitoring the toxicity in the process of treatment, and the progressionfree survival(PFS) was measured. Results:Fifteen cases dropped out because of the irreconcilable conditions which had no relationship with the treatment, 4 in the control group, 5 in the intravenous group, and 6 in the intratumor group, respectively. Compared with the control group, the response rates(complete remission + partial response) and the disease control rates(complete remission + partial response + stable disease) were significantly higher, the P-gp expressions were significantly decreased after 3 and 6 weeks of treatment, and the Kaplan-Meier survival curves of PFS were significantly longer in the intravenous and intratumor groups(P0.05 or P0.01), and the intratumor group showed better effects than the intravenous group(P0.05 or P0.01). Compared with the control group, the occurrences of rash, nausea and leukocytopenia were significantly decreased in the intravenous and intratumor groups(P0.05), but without significant difference between the intravenous and intratumor groups(P0.05). Conclusion:Aidi Injection not only improves the efficacy of NP regime, but also has the function of reducing adverse events and preventing against overexpression of P-gp induced by chemotherapy of NP regimen.     

阿托伐他汀治疗阵发性心房颤动的疗效观察及与炎性因子的关系

目的 探讨阿托伐他汀治疗阵发性心房颤动的疗效和与炎性因子的关系.方法 将83例发作频繁的阵发性心房颤动(AF)患者,随机分成治疗组(阿托伐他汀联合胺碘酮)和对照组(单用胺碘酮),随访时间半年.结果 治疗组总有效率为81.4%(35/43),对照组总有效率为57.5%(23/40),两组比较差异有统计学意义(P<0.05).两组治疗后C-反应蛋白(CRP)水平、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的水平均显著下降,且治疗组显著低于对照组,两组比较差异有统计学意义(P<0.05),两组的安全性相当.结论 阿托伐他汀能显著减少阵发性房颤的复发和降低炎性因子水平,且未增加严重不良反应. Abstract： Objective To evaluate the effect and relation to inflammatory factor of atorvastatin on paroxysmal atrial fibrillation.Methods Eighty-three patients with frequent paroxysmal atrial fibrillation were randomly divided into two groups:treatment group received atorvastatin tablet and amiodarone tablet,control group only received amiodarone tablet.All patients were followed up 6 months. Results The total effective rate in the treatment group was 81.4% and 57.5% in the control group with a significant difference (P<0.05). The level of C-reactive protein, tumor necrosis factor-α and interleukin-6 got a obviously decrease after the treatment of the two groups (P<0.05 or P<0.01).But still had a statistical significance between the two groups(P<0.05).In the course of the treatment,both groups were free from obvious side effects.Conclusions Atorvastatin can decrease the palindromia and the level of inflammatory in paroxysmal atrial fbrillation and has no side-effect.     

安氏芍倍注射液与消痔灵注射液治疗Ⅰ–Ⅲ阶段内痔的疗效比较：一项前瞻性队列研究

Objective:To compare the effect of An's Shaobei Injection(安氏勺倍注射液) with Xiaozhiling Injection(消痔灵注射液) in patients with internal hemorrhoids of grade Ⅰ-Ⅲ.Methods:This cohort study included 1,520 internal hemorrhoids patients with grade Ⅰ-Ⅲ who were scheduled for liquid injection treatment from July 2003 to July 2009.The cohort included patients who underwent either An's Shaobei Injection treatment(the treatment group,760 cases) or Xiaozhiling Injection treatment(the control group,760 cases).All patients were followed up regularly for 3 years;the observing indices included anal function recovery and clinical response after operation.Results:Among the 1,520 patients,1,508(99.2%) completed the 3-year follow-up.The efficacy rate was 97.5%in the treatment group,significantly higher than the control group(91.8%,P0.01).The recurrence rate in the treatment group was 0.5%,significantly lower than that of the control group(1.3%,P0.01).In addition,perianal callosity occurred in 8 cases(1.1%) and anorectal stricture in 26 cases(3.5%)after operation in the control group.There was no perianal callosity and anorectal stricture in the treatment group.Conclusion:The treatment with An's Shaobei Injection demonstrated superior clinical effect to Xiaozhiling Injection with fewer adverse effects.     

Effect of TCM Combined with Chemotherapy on Immune Function and Quality of Life of Patients with Non-small Cell Lung Cancer inStage Ⅲ-Ⅳ

Objective: To observe and compare the effect of traditional Chinese medicine (TCM) combined with chemotherapy (CT) on immune function and quality of life (QOL)of patients with non-small cell lung cancer (NSCLC) in stage Ⅲ-Ⅳ. Methods: One hundred cases with stage Ⅲ-Ⅳ NSCLC were randomly divided into two groups. The treated group (n=50) received CT combined with TCM, and the control group received CT alone. The percentage of T lymphocyte subset in peripheral blood and the change of natural killer (NK) cell count were observed after treatment. The QOL and tolerance of CT were also compared between the two groups after treatment. Results: In the treated group, CD3 cell count, CD4 cell count, CD4/ CDg ratio and NK cell activity were higher than those in control group, while CD8 cell count in the treated group was lower than that in the control group (P<0.05), and QOL and tolerance of CT in the treated group were also better (P<0.05). Conclusion: TCM combined with CT could raise the patients' ability in to     

Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients

OBJECTIVE: To investigate the effect of Xiaoaiping Injection (XAP) on advanced hepatocellular carcinoma (HCC) in patients. METHODS: Sixty-eight patients with advanced HCC were assigned to a control group of 36 and a treatment group of 32.The control group was treated with best supportive treatment (BST) and the treatment group was given XAP plus BST. XAP was administered daily by iv and the treatment course was lasted for 30 days for both groups.The immediate therapeutic efficacy, Karnofsky performance status (KPS) scores, and the changes in immunity indicators (CD3+, CD4+ and CD8+ T cells) were measured and compared before and after treatment. The progression-free survival (PFS) rate and overall survival (OS) rate in the 2 groups were analyzed. RESULTS: The immediate therapeutic efficacy and KPS of the treatment group were better than those in the control group (P<0.05). Patients in the treat-ment group had higher percentages of CD3 and CD4 T-lymphocytes in peripheral blood than those in the control group (P<0.05). The median survival time was 27.0 weeks in the treatment group and 24.5 weeks in the control group. The 6-months cumulative survival rates in the treatment and control groups were 33.3% and 25.0% , respectively, with no significant difference (P>0.05). The PFS was 18 weeks in the treatment group and 15 weeks in control group (P<0.05). CONCLUSION: XAP enhances the quality of life (QOL) of patients with advanced HCC, improves their immunity and extends their PFS.     

Clinical observation of Esomeprazole combined with magnesium aluminum carbonate in patients with gastric ulcer

Objective To investigate the clinical effect of esomeprazole combined with magnesium aluminum carbonate in patients with gastric ulcer. Methods A total of 106 patients with gastric ulcer who were treated in our hospital from September to September 20, 2017 were enrolled in this study. They were randomly divided into two groups, 53 patients in each group. The control group received oral esomeprazole. Study group On this basis, magnesium aluminocarbonate was added for treatment, and the total clinical effective rate and ulcer diameter of the two groups were compared. Results The total effective rate of the study group was 92.45% higher than that of the control group(77.36%)(P 0.05). The diameter of the study group was(2.21±1.83) mm. The study group was significantly lower than the control group. The difference was statistically significant(P 0.05).Conclusion The combination of esomeprazole and aluminum magnesium carbonate in gastric ulcer disease can promote the healing of gastric ulcer and improve the clinical efficacy.     

Surgical treatment of atrial fibrillation with maze procedure by radiofrequency ablation

Objective　To compare the results of treatment of atrial fibrillation (Af) with maze procedure by radiofrequency in 25 patients undergoing mitral valve replacement operation (MVRO) (treatment group) with those in 25 patients undergoing MVRO only (control group).Methods　The maze procedure modified was completed by radiofrequency ablation with macroscopy during MVRO in the treatment group, whereas the patients in the control group underwent MVRO only. No one in the two groups took antiarrhythmic drugs before and after operation.Results　The heart rhythm became stable sinus rhythm in 22 of 25 patients of the treatment group after operation and the success rate was 88.0%. Af recurred in none of the 22 patients during the follow-up for 3-24 months. In the control group, 5 patients showed transient sinus rhythm, but Af recurred when they left hospital.Conclusions　Maze procedure by radiofrequency ablation is an effective method to cure Af and its success rate was the same as that of surgical incision and cryolesion. But the former took 10-15 minutes only with light damage of atrial muscle and no bleeding, whereas the latter took 1-1.5 hours.     

Effect of Shenmai Injection(参麦注射液)on Ventricular Diastolic Function in Patients with Chronic Heart Failure:An Assessment by Tissue Doppler Imaging

<正>Objective:To assess the effect of Shenmai Injection(参麦注射液,SMI) on left ventricular diastolic function(LVDF) in patients with chronic heart failure(CHF) by tissue Doppler imaging(TDI).Methods:Sixty-four CHF patients were randomly assigned to two groups,the observation group and the control group.Basic treatment including polarized liquid therapy was given to all the patients.In addition,SMI was given to patients of the observation group.The treatment duration was 14 days.TDI was performed in all the patients 3 days prior to the initiation of the treatment and one week after the medication to measure the average movement velocity of the mitral ring of the left ventricle at the early systolic stage and late diastolic stage(Ea and Aa);the outcomes were compared with the corresponding parameters obtained from blood flow Doppler echocardiography, namely,the velocity of the E-wave(E) and A-wave(A).Results:After treatment,Ea and Ea/Aa increased and Aa decreased significantly in the observation group(P0.05).In the control group,although some improvement was seen,there was no statistically significant change(P0.05).No statistical significance was shown between groups in these parameters after treatment.Conclusion:TDI assessment shows that SMI could effectively improve the LVDF in CHF patients.     

Effect of Tanreqing Injection(痰热清注射液)on Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Chinese Medicine Syndrome of Retention of Phlegm and Heat in Fei(肺)

<正>Objective:To explore the effect of Tanreqing Injection(痰热清注射液,TRQI) on the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD) with Chinese medicine syndrome of retention of phlegm and heat in Fei(痰热阻肺证,RPHF).Methods:In a prospective randomized controlled clinical trial,90 patients with AECOPD of RPHF syndrome were randomly assigned to 3 groups,TRQI and controls A and B,each with 30 cases.The TRQI group was administered with the intravenous injections of 20 mL TRQI once a day and conventional Western medicine treatment.Control group A was administered with the intravenous injection of 15 mg ambroxol hydrochloride twice a day and conventional Western medicine treatment,and control group B was administered with conventional Western medicine treatment only.The treatments were administered for 10 days.Chinese medical symptoms and signs were scored,and plasma concentrations of interleukin(IL)-8 and neutrophil elastase(NE) were recorded.Results:(1) The Chinese medical symptoms (cough,sputum amount,expectoration,dyspnea and fever) and signs(tongue and pulse) improved significantly in the TRQI group(P0.05 or P0.01),and improvements in cough,sputum amount and expectoration were better in the TRQI group than control group B(P0.05);there was no significant difference between the TRQI group and control group A(P0.05).The sign of tongue was also improved significantly in the TRQI group (P0.05).(2) The overall effects in the TRQI group and control group A were significantly better than in control group B(P0.05),with no significant differences between the TRQI group and control group A(P0.05).There was no significant difference in the total effective rate among the three groups(P0.05).(3) After treatment, the plasma concentrations of IL-8 and NE decreased in the TRQI group and control group A(P0.05),and the concentration of IL-8 in control group B decreased(P0.05).The difference in IL-8 was greater in the TRQI group than in control group A and B before and after treatment,and the change in NE was greater in control group A than in the TRQI group and control group B,but there was no statistical significance among the three groups with regards to the change in IL-8 or NE(P0.05).Conclusion:TRQI could improved the Chinese medical signs and symptoms in the patients with AECOPD,possibly because of the decreasing plasma levels of IL-8 and NE which could improve response to airway inflammation and mucus hypersecretion.     

Effect of Chinese drugs for supplementing qi, Nourishing Yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization

Objective:To observe the effects of Chinese drugs for supplementing qi,nourishing yin and activating blood circulation on the myocardial perfusion in acute myocardial infarction(AMI) patients after revascularization.Methods:Eighty patients with anterior or inferior ventricular wall AMI,who had received revascularization by intravenous thrombolysis or coronary bypass,were randomized into the treated group and the control group equally,both treated with conventional Western medical treatment,but combined,r...     

Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on Renal Dysfunction Progression in Patients with Atherosclerotic Renal Artery Stenosis

Objective:To investigate the effect of Huanshuai Recipe Oral Liquid(缓衰口服液,HSR) on retarding the progression of renal dysfunction in patients with atherosclerotic renal artery stenosis(ARAS).Methods:A total of 52 ARAS patients with the Chinese medicine(CM) syndrome of qi deficiency and blood stasis,phlegm and dampness retention were recruited and randomly assigned into the treatment group(36 cases) and the control group(16 cases).Both groups received a basic treatment(high-quality low-protein diet,blood pressure control,lipid-lowering,correcting the acidosis,etc.).In addition,the treatment group received 20 mL HSR and the control group received placebo,3 times a day for 6 months.Renal function(serum creatinine,blood urea nitrogen and uric acid) and blood lipids(cholesterol,triglycerides and low density lipoprotein) were examined monthly.The estimated glomerular filtration rate(eGFR) and CM syndrome score were compared between groups.Results:After treatment,compared with the control group,the serum creatinine level,uric acid level and CM syndrome score of the treatment group were significantly decreased(P0.05 or P0.01),and the eGFR in the treatment group were significantly increased(P0.05).Conclusion:HSR can effectively improve the renal function and clinical symptoms of ARAS patients.     

Clinical observation on treatment of depression by electro-acupuncture combined with Paroxetine

Objective:To observe the clinical efficacy and adverse reactions of Paroxetine combined with electro-acupuncture (EA) in treating depression.Methods:Forty-two patients with depression were randomly assigned to the observation group (22 patients) treated with EA combined with Paroxetine,and the control group (20 patients) treated with Paroxetine alone,and the therapeutic course for both groups was 6 weeks.The therapeutic efficacy and adverse reactions were evaluated with scores by Hamilton depression scale (HAMD) and treatment emergent symptoms scale (TESS), respectively.Results:HAMD scores determined at the end of the 1st,2nd,4th,and 6th week of the treatment course were significantly lower in the observation group than those in the control group (P<0.05).The significant improvement rate evaluated at the end of the 6-week treatment was remarkably higher in the observation group than that in the control group (72.7% vs 40.0%).No significant difference of TESS scores was found between the two groups.Conclusion:EA combined with Paroxetine has better clinical efficacy than that of Paroxetine alone,with milder adverse reaction and quicker initiation of effect.     

Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion

Background Long-term maintenance of sinus rhythm after successful conversion of chronic atrial fibrillation （CAF）, often ameliorates patients＇ symptoms, reduces the risk of ischemic stroke and improves cardiovascular hemodynamics. This prospective study aims to evaluate the long-term efficacy and safety of very low-dose amiodarone （100 mg daily） for the maintenance of sinus rhythm after successful direct-current （DC） cardioversion in patients with CAF and rheumatic heart disease （RHD） post intervention. Methods This study was a randomized prospective trial. One day after successful DC cardioversion （remained normal sinus rhythm） in patients with CAF and RHD post intervention for more than six months and adequate anticoagulation, all were randomly administered either amiodarone 200 mg daily in group A or amiodarone 100 mg dally in group B. Results A total of 76 patients （40 men and 36 women） were examined from February 1998 to December 1999. The mean age of the patients was （664- 10） years, and the mean follow-up was （674-8） months （range 61 to 84 months）. Actuarial rates of the maintenance of sinus rhythm were similar in the two groups after 5 years of follow-up. Four patients （11%） in group A but none in group B experienced significant adverse effects that necessitated withdrawal of amiodarone. No death occurred during the study period. Conclusion A very low dose of amiodarone results in adequate long-term efficacy and is safe for maintaining sinus rhythm in patients with CAF and RHD post intervention after successful DC cardioversion.     

Effect of Astragalus Injection on Left Ventricular Remodeling in Aged Patients with Acute Early-stage Myocardial Infarction

Objective: To observe the effect of Astragalus Injection (AI) on left ventricular remodeling in aged patients with acute myocardial infarction (AMI). Methods: Patients with AMI were randomly divided into the AI group (46 cases) treated with AI and the control group (46 cases) treated conventionally. Left ventricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume index (LVESVI), anterior endocardial segmental length (ASL) and posterior endocardial segmental length (PSL) were all assessed by echocardiogram after 1 week and 4 weeks treatment. The cardiac systolic and diastolic functions were detected by nuclide gating cardiac blood pool imaging at the 4th week. Results: After four weeks' treatment, no obvious change of LVEDVI, LVESVI and ASL in the AI group was found, but these indexes increased significantly in the control group, with significant difference shown between the two groups (P<0. 05). As compared with the control group, the left ventricular ejection fraction (LVEF),     

Application of Aidi Injection (艾迪注射液) in the Bronchial Artery Infused Neo-Adjuvant Chemotherapy for stage ⅢA Non-small Cell Lung Cancer before surgical Operation

Objective: To study the effect of Aidi Injection (艾迪注射液,ADI) applied in the bronchial artery infused (BAI) neo-adjuvant chemotherapy for stage ⅢA non-small cell lung cancer (NSCLC) before surgical operation.Methods: The 60 patients with NSCLC stage ⅢA underwent two courses BAI chemotherapy before tumor incision were assigned to two groups,the treatment and the control groups,using a random number table,30 in each group.ADI (100 mL) was given to the patients in the treatment group by adding into 500 mL of 5% glucose injection for intravenous dripping once daily,starting from 3 days before each course of chemotherapy,and it lasted for 14 successive days,so a total of 28 days of administration was completed.The therapeutic effectiveness and the adverse reaction that occurred were observed,and the levels of T-lymphocyte subsets,natural killer cell activity,and interleukin-2 in peripheral blood were measured before and after the treatment.Results: The effective rate in the treatment group was higher than that in the control group (70.0% vs.56.7%,P0.05).Moreover,as compared with the control group,the adverse reaction that occurred in the treatment group was less and mild,especially in terms of bone marrow suppression and liver function damage (P0.05).Cellular immune function was suppressed in NSCLC patients,but after treatment,it ameliorated significantly in the treatment group,showing significant difference as compared with that in the control group (P0.05).Conclusion: ADI was an ideal auxiliary drug for the patients in stage ⅢA NSCLC received BAI neo-chemotherapy before surgical operation;it could enhance the effectiveness of chemotherapy,ameliorate the adverse reaction and elevate patients' cellular immune function;therefore,it is worthy for spreading in clinical practice.     

A Clinical Study on the Treatment of Urinary Infection with Zishen Tongli Jiaonang

Objective: To observe the therapeutic effects of Zishen Tongli Jiaonang (滋肾通利胶囊 capsules for nourishing the kidney and promoting urination) for treatment of urinary infection. Method: The treatment group with a control group were randomly set up. 120 patients in the control group were given antibiotics according to drug sensitive tests for orally taking or intravenous drip, while 136 patients in the treatment group were additionally given the capsules on the basis of the above-mentioned treatment. One course of treatment lasted 2 weeks. Statistical analysis on the therapeutic effects was conducted after a two-course treatment. The recurrence rates of the two groups were compared one year later. Results: The total remission rates were respectively 96.3% in the treatment group and 81.7% in the control group (P＜0.05).The recurrence rates one year later were respectively 4.4% in the treatment group and 30.0% in the control group (P＜0.01). Conclusion: The capsules show good effects for urinary infection, especially in the longterm effect.     

Clinical observation on the treatment of chloasma by Chinese herbs combined with acupuncture

Objective:To evaluate the clinical effect of Chinese herbs combined with acupuncture (CH-A) in treating chloasma.Methods:Sixty-one patients with chloasma were randomly assigned to two groups:30 in the control group and 31 in the treated group.Both groups received conventional treatment with oral intake of vitamin C and E,and external application of Quban Powder (祛斑散). Besides,the treated group also received CH-A,with the therapeutic course for both groups as 3 months.Results:The total effective rate in the treated group and the control group was 100.00% and 46.67% respectively,and the cure-effective rate was 74.19% and 13.33% respectively,all showing significant difference between the two groups (P<0.01).The scores of size and color of skin lesion and that of symptoms decreased in both groups,but the decrease in the treated group was more obvious, showing significant difference compared with those before treatment and also compared with those in the control group after treatment (P<0.05 or P<0.01).A follow-up study in 1 year to 2 years and 4 months showed that the long-term effect in the treated group showed an increasing trend compared with the effect immediately after treatment,but it showed a decreasing trend in the control group,though with no any statistical significance (both P>0.05).Conclusion:On the basis of conventional treatment, combined use of Chinese herbal medicine and acupuncture in treating chloasma could markedly improve the accompanied symptoms,lighten the color and shrink the size of skin lesions.